Literature DB >> 20679626

Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.

Michael S Ewer, Steven M Ewer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20679626     DOI： 10.1200/JCO.2010.30.6274

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  24 in total

Review 1.  Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Intern Emerg Med       Date:  2011-12-13       Impact factor: 3.397

2.  Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways.

Authors:  Polina Sysa-Shah; Carlo G Tocchetti; Manveen Gupta; Peter P Rainer; Xiaoxu Shen; Byung-Hak Kang; Frances Belmonte; Jian Li; Yi Xu; Xin Guo; Djahida Bedja; Wei Dong Gao; Nazareno Paolocci; Rutwik Rath; Douglas B Sawyer; Sathyamangla V Naga Prasad; Kathleen Gabrielson
Journal:  Cardiovasc Res       Date:  2015-12-21       Impact factor: 10.787

Review 3.  Cardiotoxicity of anticancer treatments.

Authors:  Michael S Ewer; Steven M Ewer
Journal:  Nat Rev Cardiol       Date:  2015-05-12       Impact factor: 32.419

4.  Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.

Authors:  Yasuhiro Oki; Michael S Ewer; Daniel J Lenihan; Michael J Fisch; Fredrick B Hagemeister; Michelle Fanale; Jorge Romaguera; Barbara Pro; Nathan Fowler; Anas Younes; Alan B Astrow; Xuelin Huang; Larry W Kwak; Felipe Samaniego; Peter McLaughlin; Sattva S Neelapu; Michael Wang; Luis E Fayad; Jean-Bernard Durand; M Alma Rodriguez
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-09-28

5.  Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection.

Authors:  Rosalinda Madonna; Christian Cadeddu; Martino Deidda; Donato Mele; Ines Monte; Giuseppina Novo; Pasquale Pagliaro; Alessia Pepe; Paolo Spallarossa; Carlo Gabriele Tocchetti; Concetta Zito; Giuseppe Mercuro
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

Review 6.  From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Authors:  Carlo Gabriele Tocchetti; Christian Cadeddu; Daniela Di Lisi; Saveria Femminò; Rosalinda Madonna; Donato Mele; Ines Monte; Giuseppina Novo; Claudia Penna; Alessia Pepe; Paolo Spallarossa; Gilda Varricchi; Concetta Zito; Pasquale Pagliaro; Giuseppe Mercuro
Journal:  Antioxid Redox Signal       Date:  2017-05-15       Impact factor: 8.401

7.  Cardiac complications of chemotherapy: role of biomarkers.

Authors:  Alessandro Colombo; Maria T Sandri; Michela Salvatici; Carlo M Cipolla; Daniela Cardinale
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

8.  Replacement of conventional doxorubicin by pegylated liposomal doxorubicin in standard RCHOP chemotherapy for elderly diffuse large B-Cell lymphoma: a retrospective study in China.

Authors:  De Zhou; Li Li; Changqian Bao; Jingjing Zhu; Lixia Zhu; Xiudi Yang; Yanlong Zheng; Meng Zhou; Xuxia Luo; Wanzhuo Xie; Xiujin Ye
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 9.  Cardiac toxicity of anticancer agents.

Authors:  Alessandro Colombo; Carlo Cipolla; Marta Beggiato; Daniela Cardinale
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

Review 10.  Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.

Authors:  Marco Bruno Morelli; Chiara Bongiovanni; Silvia Da Pra; Carmen Miano; Francesca Sacchi; Mattia Lauriola; Gabriele D'Uva
Journal:  Front Cardiovasc Med       Date:  2022-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.